Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand

Journal of Controlled Release

Volumn 155, Issue 2, 2011, Pages 211-217

  Lee, Ga Young ^a   Kim, Jong Ho ^a   Oh, Goo Taeg ^b   Lee, Byung Heon ^a   Kwon, Ick Chan ^c   Kim, In San ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Ewha Womans University   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

Atherosclerosis; Nanoparticles; Phage display; Stabilin 2; Targeting

Indexed keywords

ATHEROSCLEROSIS; ATHEROSCLEROTIC LESIONS; ATHEROSCLEROTIC PLAQUE; HYDROPHOBICALLY MODIFIED GLYCOL CHITOSANS; IN-VITRO; IN-VIVO; INFLAMMATORY DISEASE; LYMPH NODE; MOLECULAR IMAGING; MOLECULAR TARGETING; NORMAL VESSELS; PEPTIDE LIGAND; PHAGE DISPLAY; PHAGE DISPLAY TECHNOLOGY; SMOOTH MUSCLE CELLS; STABILIN-2; TARGETING; TRANS-MEMBRANE PROTEINS;

DISEASES; DRUG DELIVERY; GLYCOLS; MACROPHAGES; MAMMALS; MUSCLE; NANOPARTICLES; PEPTIDES; ENDOTHELIAL CELLS; MOLECULAR IMAGING;

ENDOTHELIAL CELLS; PEPTIDES;

CHITOSAN; MEMBRANE PROTEIN; NANOPARTICLE; RECOMBINANT PROTEIN; STABILIN 2; STABILIN 2 BINDING PEPTIDE; UNCLASSIFIED DRUG; FLUORESCEIN ISOTHIOCYANATE; PROTEIN; S2P PROTEIN; STABILIN 2 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; ADULT; AGED; AMINO ACID SEQUENCE; LYMPH NODE;

AMINO ACID SEQUENCE; ANIMALS; AORTA; APOLIPOPROTEINS E; CELL ADHESION MOLECULES, NEURONAL; CELL LINE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; FEMALE; FEMORAL ARTERY; LIGANDS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; OLIGOPEPTIDES; PEPTIDE LIBRARY; PLAQUE, ATHEROSCLEROTIC; PROTEIN BINDING; RECEPTORS, LDL;

EID: 80054090725     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.07.010     Document Type: Conference Paper

References (44)

1. D. Peters, M. Kastantin, V. Kotamraju, P. Karmali, K. Gujraty, M. Tirrell, and E. Ruoslahti Targeting atherosclerosis by using modular, multifunctional micelles Proc. Natl. Acad. Sci. U. S. A. 106 2009 9815
2. S. Subcommittee Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 117 2008 e25
3. P. Libby, P. Ridker, and A. Maseri In ammation and atherosclerosis Nature 420 2002 868 874
4. A. Lindsay, and R. Choudhury Form to function: current and future roles for atherosclerosis imaging in drug development Nat. Rev. Drug Discov. 7 2008 517 529 (Pubitemid 351767119)
5. N. Manicke, M. Nefliu, C. Wu, J. Woods, V. Reiser, R. Hendrickson, and R. Cooks Imaging of lipids in atheroma by desorption electrospray ionization mass spectrometry Anal. Chem. 81 2009 8702 8707
6. K. Douma, L. Prinzen, D.W. Slaaf, C.P.M. Reutelingsperger, E.A.L. Biessen, T.M. Hackeng, M.J. Post, and M.A.M.J. van Zandvoort Nanoparticles for optical molecular imaging of atherosclerosis Small 5 2009 544 557
7. A. Broisat, L. Riou, V. Ardisson, D. Boturyn, P. Dumy, D. Fagret, and C. Ghezzi Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p Eur. J. Nucl. Med. Mol. Imaging 34 2007 830 840 (Pubitemid 46798952)
8. F.A. Jaffer, D.E. Kim, L. Quinti, C.H. Tung, E. Aikawa, A.N. Pande, R.H. Kohler, G.P. Shi, P. Libby, and R. Weissleder Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor Circulation 115 2007 2292
9. L. Prinzen, R.J.J.H.M. Miserus, A. Dirksen, T.M. Hackeng, N. Deckers, N.J. Bitsch, R.T.A. Megens, K. Douma, J.W. Heemskerk, and M.E. Kooi Optical and magnetic resonance imaging of cell death and platelet activation using annexin A5-functionalized quantum dots Nano Lett. 7 2007 93 100 (Pubitemid 46225835)
10. P.M. Winter, A.M. Neubauer, S.D. Caruthers, T.D. Harris, J.D. Robertson, T.A. Williams, A.H. Schmieder, G. Hu, J.S. Allen, and E.K. Lacy Endothelial {alpha}{nu}{beta} 3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis Arterioscler. Thromb. Vasc. Biol. 26 2006 2103
11. R.M. Botnar, A.S. Perez, S. Witte, A.J. Wiethoff, J. Laredo, J. Hamilton, W. Quist, E.C. Parsons Jr., A. Vaidya, and A. Kolodziej In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent Circulation 109 2004 2023
12. R.T.A. Megens, M.G.A. Oude Egbrink, J.P.M. Cleutjens, M.J.E. Kuijpers, P.H.M. Schiffers, M. Merkx, D.W. Slaaf, and M.A.M.J. van Zandvoort Imaging collagen in intact viable healthy and atherosclerotic arteries using fluorescently labeled CNA35 and two-photon laser scanning microscopy Mol. Imaging 6 2007 247 260 (Pubitemid 47509829)
13. H. Hong, H. Lee, W. Kwak, J. Yoo, M. Na, I. So, T. Kwon, H. Park, S. Huh, and G. Oh Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis J. Cell. Mol. Med. 12 2008 2003 2014
14. N. Thapa, H. Hong, P. Sangeetha, I. Kim, J. Yoo, K. Rhee, G. Oh, I. Kwon, and B. Lee Identification of a peptide ligand recognizing dysfunctional endothelial cells for targeting atherosclerosis J. Control. Release 131 2008 27 33
15. P. McCourt, B. Smedsrød, J. Melkko, and S. Johansson Characterization of a hyaluronan receptor on rat sinusoidal liver endothelial cells and its functional relationship to scavenger receptors Hepatology 30 1999 1276 1286 (Pubitemid 29510867)
16. Y. Tamura, H. Adachi, J. Osuga, K. Ohashi, N. Yahagi, M. Sekiya, H. Okazaki, S. Tomita, Y. Iizuka, and H. Shimano FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products J. Biol. Chem. 278 2003 12613
17. H. Adachi, and M. Tsujimoto FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities J. Biol. Chem. 277 2002 34264
18. S. Park, M. Jung, and I. Kim Stabilin-2 mediates homophilic cell-cell interactions via its FAS1 domains FEBS Lett. 583 2009 1375 1380
19. B. Zhou, J. Weigel, L. Fauss, and P. Weigel Identification of the hyaluronan receptor for endocytosis (HARE) J. Biol. Chem. 275 2000 37733
20. M. Falkowski, K. Schledzewski, B. Hansen, and S. Goerdt Expression of stabilin-2, a novel fasciclin-like hyaluronan receptor protein, in murine sinusoidal endothelia, avascular tissues, and at solid/liquid interfaces Histochem. Cell Biol. 120 2003 361 369 (Pubitemid 38005355)
21. S. Park, M. Jung, H. Kim, S. Lee, S. Kim, B. Lee, T. Kwon, R. Park, and I. Kim Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor Cell Death Differ. 15 2007 192 201 (Pubitemid 350286187)
22. M. Jung, S. Park, and I. Kim Stabilin-2 is involved in lymphocyte adhesion to the hepatic sinusoidal endothelium via the interaction with alpha M 2 integrin J. Leukoc. Biol. 82 2007 1156
23. R. Kittelberger, P. Davis, and W. Stehbens An improved immunofluorescence technique for the histological examination of blood vessel tissue Acta Histochem. 86 1989 137
24. K. Park, J. Kim, Y. Nam, S. Lee, H. Nam, K. Kim, J. Park, I. Kim, K. Choi, and S. Kim Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles J. Control. Release 122 2007 305 314 (Pubitemid 47404663)
25. S. Kwon, J. Park, H. Chung, I. Kwon, and S. Jeong Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5-cholanic acid Langmuir 19 2003 10188 10193
26. K. Kim, J. Kim, S. Kim, H. Chung, K. Choi, I. Kwon, J. Park, Y. Kim, R. Park, and I. Kim Self-assembled nanoparticles of bile acid-modified glycol chitosans and their applications for cancer therapy Macromol. Res. 13 2005 167 175 (Pubitemid 40935080)
27. J. Kim, Y. Kim, S. Kim, J. Park, K. Kim, K. Choi, H. Chung, S. Jeong, R. Park, and I. Kim Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel J. Control. Release 111 2006 228 234 (Pubitemid 43290012)
28. K. Park, H. Hong, H. Moon, B. Lee, I. Kim, I. Kwon, and K. Rhee A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides J. Control. Release 128 2008 217 223
29. Y. Nakamura, Y. Horii, T. Nishino, H. Shiiki, Y. Sakaguchi, T. Kagoshima, K. Dohi, Z. Makita, H. Vlassara, and R. Bucala Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus Am. J. Pathol. 143 1993 1649
30. K. Takahashi, M. Takeya, and N. Sakashita Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals Med. Electron Microsc. 35 2002 179 203 (Pubitemid 36205679)
31. T. Sudhof The synaptic vesicle cycle Annu. Rev. Neurosci. 27 2004 509
32. J. Rizo, X. Chen, and D. Ara Unraveling the mechanisms of synaptotagmin and SNARE function in neurotransmitter release Trends Cell Biol. 16 2006 339 350 (Pubitemid 44062312)
33. E. Chapman How does synaptotagmin trigger neurotransmitter release? Biochemistry 77 2008 615
34. I. Fernandez, D. Ara, J. Ubach, S. Gerber, O. Shin, Y. Gao, R. Anderson, T. Südhof, and J. Rizo Three-dimensional structure of the synaptotagmin 1 C2B-domain: synaptotagmin 1 as a phospholipid binding machine Neuron 32 2001 1057 1069 (Pubitemid 34075396)
35. 2+-activated neurotransmitter release Cell 74 1993 1125 1134 (Pubitemid 23289468)
36. W. Fang, S. Ji, F. Wang, M. Yang, B. Lü, L. Liu, Z. Wang, and Z. He Noninvasive detection of experimental vulnerable atherosclerotic plaques with 99Tc m labeled C2A domain of synaptotagmin I Zhonghua Xin Xue Guan Bing Za Zhi 35 2007 178
37. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283
38. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760 (Pubitemid 350223348)
39. J.H. Park, S. Kwon, J.O. Nam, R.W. Park, H. Chung, S.B. Seo, I.S. Kim, I.C. Kwon, and S.Y. Jeong Self-assembled nanoparticles based on glycol chitosan bearing 5 [beta]-cholanic acid for RGD peptide delivery J. Control. Release 95 2004 579 588 (Pubitemid 38340507)
40. K. Kim, J.H. Kim, H. Park, Y.S. Kim, K. Park, H. Nam, S. Lee, J.H. Park, R.W. Park, and I.S. Kim Tumor-homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring J. Control. Release 146 2010 219 227
41. R.P. Choudhury, V. Fuster, and Z.A. Fayad Molecular, cellular and functional imaging of atherothrombosis Nat. Rev. Drug Discov. 3 2004 913 925 (Pubitemid 39529929)
42. M. Nahrendorf, F.A. Jaffer, K.A. Kelly, D.E. Sosnovik, E. Aikawa, P. Libby, and R. Weissleder Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis Circulation 114 2006 1504
43. V. Amirbekian, M. Lipinski, K. Briley-Saebo, S. Amirbekian, J. Aguinaldo, D. Weinreb, E. Vucic, J. Frias, F. Hyafil, and V. Mani Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI Proc. Natl. Acad. Sci. U. S. A. 104 2007 961
44. M. Oostendorp, K. Douma, T.M. Hackeng, A. Dirksen, M.J. Post, M.A.M.J. van Zandvoort, and W.H. Backes Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots Cancer Res. 68 2008 7676